RESPONSE BIOMEDICAL CORP·4

Mar 23, 8:17 PM ET

RESPONSE BIOMEDICAL CORP 4

4 · RESPONSE BIOMEDICAL CORP · Filed Mar 23, 2015

Insider Transaction Report

Form 4
Period: 2015-03-19
Transactions
  • Award

    Common Stock

    2015-03-19+6,25037,929 total
  • Award

    Stock Option (Right to Buy)

    2015-03-19+5,0005,000 total
    Exercise: $0.92Exp: 2025-03-19Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date.
  • [F2]Exercise prices shown are denominated in Canadian dollars.
  • [F3]100% of the options vest on March 20, 2016, subject to the reporting person's continued service as a director of the Company through each vesting date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4